Released fibroblast growth factor18 from a collagen membrane induces osteoblastic activity involved with downregulation of miR-133a and miR-135a

Abstract

We have developed a unique delivery system of growth factors using collagen membranes (CMs) to induce bone regeneration. We hypothesized that fibroblast growth factor18 (FGF-18), a pleiotropic protein that stimulates proliferation in several tissues, can be a good candidate to use our delivery system for bone regeneration. Cell viability, cell proliferation, alkaline phosphatase activity, mineralization, and marker gene expression of osteoblastic differentiation were evaluated after mouse preosteoblasts were cultured with a CM containing FGF-18, a CM containing platelet-derived growth factor, or a CM alone. Furthermore, expression of microRNA, especially miR-133a and miR-135a involving inhibition of osteogenic factors, was measured in preosteoblasts with CM/FGF-18 or CM alone. A sustained release of FGF-18 from the CM was observed over 21 days. CM/FGF-18 significantly promoted cell proliferation, alkaline phosphatase activity, and mineralization compared to CM alone. Gene expression of type I collagen, runt-related transcription factor 2, osteocalcin, Smad5, and osteopontin was significantly upregulated in CM/FGF-18 compared to CM alone, and similar to CM/platelet-derived growth factor. Additionally, CM/FGF-18 downregulated expression of miR-133a and miR-135a. These results suggested that released FGF-18 from a CM promotes osteoblastic activity involved with downregulation of miR-133a and miR-135a.

Keywords

Fibroblast growth factor-18 microRNA collagen membrane bone regeneration osteoblasts signaling pathway

Get full access to this article

View all access options for this article.

References

Needleman

Worthington

and Giedrys-Leeper

et al. Guided tissue regeneration for periodontal infra-bony defects. Cochrane Database Syst Rev 2006; 19: CD001724.

Yamano

Lin

Dai

et al . Bioactive collagen membrane as a carrier of sustained release of PDGF. J Tissue Sci Eng 2011; 2: 110.

Yamano

Haku

Yamanaka

et al . The effect of a bioactive collagen membrane releasing PDGF or GDF-5 on bone regeneration. Biomaterials 2014; 35: 2446–2453.

Takayama

Dai

Tachi

et al . The potential of stromal cell-derived factor-1 delivery using a collagen membrane for bone regeneration. J Biomater Appl 2017; 31: 1049–1061.

Ozaki

Takayama

Yamamoto

et al . A collagen membrane containing osteogenic protein-1 facilitates bone regeneration in a rat mandibular bone defect. Arch Oral Biol 2017; 84: 19–28.

Ohbayashi

Hoshikawa

Kimura

et al . Structure and expression of the mRNA encording a novel fibroblast growth factor, FGF-18. J Biol Chem 1998; 273: 18161–11864.

Yun

Won

Jeon

et al . Fibroblast growth factors: biology, function, and application for tissue regeneration. J Tissue Eng 2010; 7: 218142.

Ohbayashi

Shibayama

Kurotaki

et al . FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev 2002; 16: 870–879.

Liu

Colvin

et al . Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18. Genes Dev 2002; 16: 859–869.

10.

Qiu

Wang

et al . FGF-18, a novel member of the fibroblast growth factor family, stimulates hepatic and intestinal proliferation. Mol Cell Biol 1998; 18: 6063–6074.

11.

Hamidouche

Fromigué

Nuber

et al . Autocrine fibroblast growth factor 18 mediates dexamethasone-induced osteogenic differentiation of murine mesenchymal stem cells. J Cell Physiol 2010; 224: 509–515.

12.

Jeon

Yun

Kang

et al . Investigating the role of FGF18 in the cultivation and osteogenic differentiation of mesenchymal stem cells. PLoS One 2012; 7: e43982.

13.

Lian

Stein

van Wijnen

et al . MicroRNA control of bone formation and homeostasis. Nat Rev Endocrinol 2012; 8: 212–227.

14.

Ambros

MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell 2003; 113: 673–676.

15.

Ambros

The functions of animal microRNAs. Nature 2004; 431: 350–355.

16.

Zheng

Shi

et al . miR-1297 regulates neural stem cell differentiation and viability through controlling Hes1 expression. Cell Prolif 2017; 50. DOI: 10.1111/cpr.12347

17.

and Li

YP.

Over-expression of miR-1271 inhibits endometrial cancer cells proliferation and induces cell apoptosis by targeting CDK1. Eur Rev Med Pharmacol Sci 2017; 21: 2816–2822.

18.

Yao

Zhang

et al . MicroRNA-215 acts as a tumor suppressor in breast cancer by targeting AKT serine/threonine kinase 1. Oncol Lett 2017; 14: 1097–1104.

19.

Itoh

Ando

Tsukamasa

et al . Expression of BMP-2 and Ets1 in BMP-2-stimulated mouse pre-osteoblast differentiation is regulated by microRNA-370. FEBS Lett 2012; 586: 1693–1701.

20.

Long

Sun

Cheng

et al . miR-139-5p Represses BMSC osteogenesis via targeting Wnt/β-catenin signaling pathway. DNA Cell Biol 2017; 36: 715–724.

21.

Gao

et al . miR-365 ameliorates dexamethasone-induced suppression of osteogenesis in MC3T3-E1 cells by targeting HDAC4. Int J Mol Sci 2017; 4: 18.

22.

Hassan

Volinia

et al . A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proc Natl Acad Sci USA 2008; 16: 13906–13911.

23.

Mahapatra

Singh

Kim

et al . Osteopromoting reservoir of stem cells: bioactive mesoporous nanocarrier/collagen gel through slow-releasing FGF18 and the activated BMP signaling. ACS Appl Mater Interfaces 2016; 8: 27573–27584.

24.

Tollemar

Collier

Mohammed

et al . Stem cells, growth factors and scaffolds in craniofacial regenerative medicine. Genes Dis 2016; 3: 56–71.

25.

van Hout

Mink van der Molen

Breugem

et al . Reconstruction of the alveolar cleft: can growth factor-aided tissue engineering replace autologous bone grafting? A literature review and systematic review of results obtained with bone morphogenetic protein-2. Clin Oral Invest 2011; 15: 297–303.

26.

Sukul

Nguyen

Min

et al . Effect of local sustainable release of BMP2-VEGF from nano-cellulose loaded in sponge biphasic calcium phosphate on bone regeneration. Tissue Eng Part A 2015; 21: 1822–1836.

27.

Lieberman

Daluiski

and Einhorn

TA.

The role of growth factors in the repair of bone. Biology and clinical applications. J Bone Joint Surg Am 2002; 84: 1032–1044.

28.

Nevins

Giannobile

McGuire

et al . Platelet-derived growth factor stimulates bone fill and rate of attachment level gain: results of a large multicenter randomized controlled trial. J Periodontol 2005; 76: 2205–2215.

29.

Singh

Patel

Lee

et al . Potential of magnetic nanofiber scaffolds with mechanical and biological properties applicable for bone regeneration. PLoS One 2014; 9: e91584.

30.

Stein

Lian

and Owen

TA.

Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. Faseb J 1990; 4: 3111–3123.

31.

Lee

Kim

et al . Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol 2000; 20: 8783–8792.

32.

Bokui

Otani

Igarashi

et al . Involvement of MAPK signaling molecules and Runx2 in the NELL1-induced osteoblastic differentiation. FEBS Lett 2008; 23:582: 365–371.

33.

Komori

Signaling networks in RUNX2-dependent bone development. J Cell Biochem 2011; 112: 750–755.

34.

Komori

Yagi

Nomura

et al . Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997; 89: 755–764.

35.

Otto

Thornell

Crompton

et al . Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997; 89: 765–771.

36.

Behr

Sorkin

Manu

et al . FGF-18 is required for osteogenesis but not angiogenesis during long bone repair. Tissue Eng Part A 2011; 17: 2061–2069.

37.

Shimoaka

Ogasawara

Yonamine

et al . Regulation of osteoblast, chondrocyte, and osteoclast functions by fibroblast growth factor (FGF)-18 in comparison with FGF-2 and FGF-10. J Biol Chem 2002; 277: 7493–7500.

38.

Guo

and Wang

XF.

Signaling cross-talk between TGF-beta/BMP and other pathways. Cell Res 2009; 19: 71–88.

39.

Liu

Viggeswarapu

et al . Activation of c-Jun NH(2)-terminal kinase 1 increases cellular responsiveness to BMP-2 and decreases binding of inhibitory Smad6 to the type 1 BMP receptor. J Bone Miner Res 2011; 26: 1122–1132.

40.

Yoo

Kim

Song

et al.

Calcium supplement derived from Gallus gallus domesticus promotes BMP-2/RUNX2/SMAD5 and suppresses TRAP/RANK expression through MAPK signaling activation. Nutrients 2017; 9: 504.

41.

Bartel

DP.

MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281–297.

42.

Wienholds

Kloosterman

Miska

et al . MicroRNA expression in zebrafish embryonic development. Science 2005; 309: 310–311.

43.

Kahai

Lee

et al . MicroRNA miR-378 regulates nephronectin expression modulating osteoblast differentiation by targeting GalNT-7. PLoS One 2009; 4: e7535.

44.

Hassan

Gordon

Beloti

et al . A network connecting Runx2, SATB2, and the miR-23a∼27a∼24-2 cluster regulates the osteoblast differentiation program. Proc Natl Acad Sci USA 2010; 107: 19879–19884.

45.

You

Chen

et al . MiR-378 overexpression attenuates high glucose-suppressed osteogenic differentiation through targeting CASP3 and activating PI3K/Akt signaling pathway. Int J Clin Exp Pathol 2014; 7: 7249–7261.

46.

Nakasa

Yoshizuka

Andry Usman

et al . MicroRNAs and bone regeneration. Curr Genom 2015; 16: 441–452.

47.

Lin

et al . MiR-135a suppresses calcification in senescent VSMCs by regulating KLF4/STAT3 pathway. Curr Vasc Pharmacol 2016; 14: 211–218.

48.

Chen

Mandel

Thomson

et al . The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 2006; 38: 228–233.

49.

Liao

Zhang

Yuan

et al . MiR-133a modulates osteogenic differentiation of vascular smooth muscle cells. Endocrinology 2013; 154: 3344–3352.

50.

Wang

Moore

et al . MiR-133a in human circulating monocytes: a potential biomarker associated with postmenopausal osteoporosis. PLoS One 2012; 7: e34641.

51.

Schaap-Oziemlak

Raymakers

Bergevoet

et al . MicroRNA hsa-miR-135b regulates mineralization in osteogenic differentiation of human unrestricted somatic stem cells. Stem Cells Dev 2010; 19: 877–885.